Where are people being tested for anti-HCV in England? Results from sentinel laboratory surveillance

L. J. Brant, M. Hurrelle, M. A. Balogun, P. Klapper, M. E. Ramsay, Hamid Jalal, Rachael Smith, Rolf Meigh, Tony Vicca, Ferial Ahmad, Imad Ibrahim, Koye Balogun, Lisa Brant, Mary Ramsay, Emily Tweed, Clive Taylor, Jeff Taylor, Elizabeth Boxall, Janet Mowbray, Antony HaleMartin Hurrelle, Darren Lyons, Mark Zuckerman, David Johnson, Paul Klapper, Ken Mutton, Keith Paver, Andrew Turner, Will Irving, Lisa Prichett, Geoff Benge, Bharat C. Patel, Josephine Silles, Lynne Ashton, Ian Hart, Ines Ushiro-Lumb, Hasan Al-Ghusein, Phil Rice, Graham Hewitt, Gillian Underhill, Emma Aarons, Peter Luton, James Nash, Mark Baker

    Research output: Contribution to journalArticlepeer-review

    Abstract

    Many people infected with hepatitis C virus (HCV) are unaware of their infection and are, therefore. potentially infectious to others. To enable effective case-finding policies to be developed, an understanding of where people, and injecting drug users (IDUs) in particular, are accessing HCV antibody testing is needed. HCV antibody testing data were collected electronically from 21 sentinel laboratories in England between 2002 and 2006 in this cross-sectional study. Service types of the physician requesting the HCV test were identified and classified. Differences in people being tested in each service type and over time were investigated. Over half a million people were tested in 5 years. Whilst most testing took place in hospital, a large proportion of people were tested in community care, particularly in general practice surgeries and genito-urinary medicine clinics. Younger people were more likely to be tested in community care, and there was evidence that testing differed according to ethnic status. IDUs were tested in all parts of the health services, although the highest proportion positive were from prisons and specialist services for drug users. Testing increased between 2002 and 2005 whilst the proportion of people testing positive declined. Routine laboratory data can provide valuable information on where people are being tested for HCV. Risk exposures should be investigated and testing targeted to people at higher risk for infection. Local laboratories should review data on testing locations and proportion positive to inform local initiatives to improve testing and yield. © 2008 The Authors.
    Original languageEnglish
    Pages (from-to)729-739
    Number of pages10
    JournalJournal of Viral Hepatitis
    Volume15
    Issue number10
    DOIs
    Publication statusPublished - Oct 2008

    Keywords

    • England
    • Hepatitis C
    • Injecting drug use
    • Surveillance
    • Testing

    Fingerprint

    Dive into the research topics of 'Where are people being tested for anti-HCV in England? Results from sentinel laboratory surveillance'. Together they form a unique fingerprint.

    Cite this